Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
Envoy Medical presented positive initial 6-month data from the first 10 patients in the pivotal study of its fully implanted Acclaim cochlear implant. Interim results showed a 24 percentage point improvement in speech recognition scores and no serious adverse events, with participants reporting 24-hour daily wear time.
Key figures
- Drug Name
- Acclaim cochlear implant
- Phase Of Trial
- pivotal
- Patients interim analysis
- 10
- Daily wear time median hours
- 24
- Pre op wear time median hours
- 15.5
- Cnc word recognition pre op percent
- 15.2
- Cnc word recognition 6 month percent
- 39.2
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.